Genomic Vision
Biotechnology company specialized in molecular diagnostics solutions and in the development of DNA detection tools used for research and in vitro diagnosis
An innovative company in Clinical Diagnosis
Genomic Vision’s technology opens a new perspective for the structural and functional analysis of the genome
The technology combines Molecular Combing, a proprietary technique to untangle single DNA molecules, with a unique detection strategy, the Genomic Morse Code. Genomic Vision’s solution fulfills an unmet medical and research need by enabling the
23/06/2017
Researchers have capture the replication of a single DNA molecule on video for the first time.
DNA replication filmed for first time shows how awkward and random genetics is DNA: It's just like us.
20/06/2017
Genomic Vision supports the world FSHD Day and the patients, families and physicians it serves every day
https://www.fshsociety.org/
23/05/2017
Le Revenu – Interview of Stephane Altaba, VP Corporate Development of Genomic Vision following the technological collaboration signed with AstraZeneca in oncology to study WEE1 inhibition using Molecular Combing
Stéphane Altaba : «Notre objectif est de signer d’autres partenariats» La biotech, issue de l’institut Pasteur et spécialisée dans le diagnostic moléculaire, a annoncé, mardi 23 mai, la signature d’un partenariat avec le géant britannique de la pharmacie Astra-Zeneca.
09/05/2017
Save the date - May 10 - - R&D day - Presentation diagnostic programs
28/02/2017
Today is !
Genomic Vision’s supports Rare Disease Day and the FSHD patients, families, and physicians it serves every day.
http://www.rarediseaseday.org/
Rare Disease Day 2017 - 28 Feb The main objective of Rare Disease Day 2017 is to raise awareness with policy makers and the public of rare diseases and of their impact on the lives of patients, and to reinforce their importance as a public health priority.
24/01/2017
TCGA study identifies genomic features of cervical cancer
https://lc.cx/JcE5
TCGA study identifies genomic features of cervical cancer Using The Cancer Genome Atlas scientists have identified novel genomic characteristics of cervical cancer that could be used to target therapies
10/01/2017
Press Release: Financial information at December 31st, 2016.
Genomic Vision doubles its installed base of FiberVision® platforms and quadruples its sales of products & services.
https://miniurl.be/r-1apg
Press Releases | Genomic Vision Financial information at September 30, 2016 and implementation of a flexible financing via the reserved issuance of convertible notes with warrants
06/01/2017
Genomic Vision will participate at the Keystone Symposia on Molecular and Cellular Biology Precision Engineering taking place in Colorado.
We look forward to discussing about our solutions for genome engineering https://lc.cx/JimP
06/01/2017
CRISPR will be a huge story in 2017. Here are 7 things to look for. The gene-editing tool’s potential to upend science is dizzying.
30/11/2016
Come visit us at at in . http://www.pasteur-network-meeting2016.org/
25/03/2016
Maximization of Molecular Combing’s potential on the Life Sciences Research Tools market http://goo.gl/ilfCr1
Startegy 2016 | Genomic Vision > Maximization of molecular combing’s potential: targeting of the major and accessible Life Sciences Research Tools (LSRT) market
Cliquez ici pour réclamer votre Listage Commercial.
Type
Adresse
80 Rue Des Meuniers
Paris
92220